The bill amends section 383.14 of the Florida Statutes to enhance newborn screening requirements. Specifically, it mandates that, starting January 1, 2027, and subject to legislative appropriation, all newborns must be screened for Duchenne muscular dystrophy. This addition is part of a broader effort to ensure that newborns are tested for various metabolic disorders and hereditary conditions, as recommended by the Genetics and Newborn Screening Advisory Council.

In the revised language, the bill specifies that the Department of Health must adopt rules requiring every newborn to undergo blood screening before reaching one week of age and to be tested for conditions included in the federal Recommended Uniform Screening Panel. The amendment also clarifies that the department will expand screening to include newly recommended conditions within 18 months, provided that an FDA-approved test is available. The deletion of the word "and" before the new requirement for Duchenne muscular dystrophy screening indicates a structural change in the list of screening requirements. The act is set to take effect on July 1, 2025.

Statutes affected:
H 1089 Filed: 383.14
H 1089 c1: 383.14
H 1089 c2: 383.14
H 1089 er: 383.14